Angiotensin II receptor blockers (ARBs) have been found to upregulate ACE2 and to be protective in hypertensive patients infected by SARS-CoV-2, rendering them potential inhibitors that may prevent infection [71]. This evidence concerns the gene ACE2 and infection.